Literature DB >> 16734386

Actin binding activity of subunit B of vacuolar H+-ATPase is involved in its targeting to ruffled membranes of osteoclasts.

Jian Zuo1, Jin Jiang, Shih-Hua Chen, Sandra Vergara, Yan Gong, Jing Xue, Haobo Huang, Masato Kaku, L Shannon Holliday.   

Abstract

UNLABELLED: Adeno-associated virus was used to transduce primary mouse osteoclasts with the B1 isoform of vacuolar H(+)-ATPase. B1, which is not normally expressed in osteoclasts, was correctly targeted to ruffled membranes of resorbing osteoclasts. Mutant subunit B1 that lacked a functional actin-binding site did not accumulate in ruffled membranes.
INTRODUCTION: The B1 "kidney" and B2 "brain" isoforms of subunit B of vacuolar H(+)-ATPase (V-ATPase) have actin binding sites that mediate interactions between the intact enzyme and filamentous-actin. Accumulating data support the hypothesis that the actin binding activity in subunit B is required for targeting of V-ATPases to the ruffled plasma membrane of osteoclasts. This study was designed to directly test this hypothesis.
MATERIALS AND METHODS: Osteoclasts express B2, but not B1. Adeno-associated virus vectors were used to transduce mouse osteoclasts with wildtype B1 or B1(mut), a full-length B subunit that contained minor alterations that disrupted actin-binding activity. Immunofluorescence was performed using polyclonal antibodies specific for subunit E, B2, and B1 of V-ATPase. Immunoprecipitations were performed using an anti-E subunit antibody. Microfilaments were detected with phalloidin and actin rings were stained with phalloidin or anti-vinculin antibodies. Images were collected using a confocal microscope.
RESULTS: Immunoprecipitations of transduced osteoclasts suggested that both B1 and B1(mut) assembled with endogenous V-ATPase subunits to form intact enzyme in osteoclasts. Both B1 and B1(mut) were localized like endogenous V-ATPase subunits in unactivated osteoclasts. Wildtype B1 associated with the detergent-insoluble cytoskeleton and was transported to ruffled membranes of resorbing osteoclasts. In contrast, B1(mut) failed to associate with the actin cytoskeleton and was not transported efficiently to ruffled membranes.
CONCLUSIONS: The B1 isoform of B subunit contains the necessary information for targeting to the ruffled membranes of osteoclasts even though it is not normally expressed in osteoclasts. The actin binding activity of B1 is involved in proper ruffled membrane targeting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16734386     DOI: 10.1359/jbmr.060201

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

1.  Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis.

Authors:  Edgardo J Toro; Jian Zuo; David A Ostrov; Dana Catalfamo; Vivian Bradaschia-Correa; Victor Arana-Chavez; Aliana R Caridad; John K Neubert; Thomas J Wronski; Shannon M Wallet; L Shannon Holliday
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

2.  Bis-enoxacin inhibits bone resorption and orthodontic tooth movement.

Authors:  E J Toro; J Zuo; A Gutierrez; A Guiterrez; R L La Rosa; A J Gawron; V Bradaschia-Correa; V Arana-Chavez; C Dolce; M F Rivera; L Kesavalu; I Bhattacharyya; J K Neubert; L S Holliday
Journal:  J Dent Res       Date:  2013-08-19       Impact factor: 6.116

3.  The regulation of osteoclast function and bone resorption by small GTPases.

Authors:  Cecile Itzstein; Fraser P Coxon; Michael J Rogers
Journal:  Small GTPases       Date:  2011-05

4.  Regulation of vacuolar H(+)-ATPase in microglia by RANKL.

Authors:  Eric M Serrano; Ryan D Ricofort; Jian Zuo; Noelle Ochotny; Morris F Manolson; L Shannon Holliday
Journal:  Biochem Biophys Res Commun       Date:  2009-08-26       Impact factor: 3.575

Review 5.  Osteopetrosis: genetics, treatment and new insights into osteoclast function.

Authors:  Cristina Sobacchi; Ansgar Schulz; Fraser P Coxon; Anna Villa; Miep H Helfrich
Journal:  Nat Rev Endocrinol       Date:  2013-07-23       Impact factor: 43.330

6.  Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening.

Authors:  David A Ostrov; Andrew T Magis; Thomas J Wronski; Edward K L Chan; Edgardo J Toro; Richard E Donatelli; Kristen Sajek; Ireni N Haroun; Michael I Nagib; Ana Piedrahita; Ashley Harris; L Shannon Holliday
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

7.  Periodontitis in rats induces systemic oxidative stress that is controlled by bone-targeted antiresorptives.

Authors:  Sehkar Oktay; Sasanka S Chukkapalli; Mercedes F Rivera-Kweh; Irina M Velsko; L Shannon Holliday; Lakshmyya Kesavalu
Journal:  J Periodontol       Date:  2015-01       Impact factor: 6.993

Review 8.  Calcium signalling and calcium transport in bone disease.

Authors:  H C Blair; P H Schlesinger; C L H Huang; M Zaidi
Journal:  Subcell Biochem       Date:  2007

9.  Bundling actin filaments from membranes: some novel players.

Authors:  Clément Thomas
Journal:  Front Plant Sci       Date:  2012-08-24       Impact factor: 5.753

10.  Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts.

Authors:  María del Mar Arriero; Joana M Ramis; Joan Perelló; Marta Monjo
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.